Method of treating pain by administering 24 hour oral opioid formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5672360
SERIAL NO

08578688

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Patients are treated with 24-hour oral sustained release opioid formulations which, upon administration, provide an initially rapid opioid absorption such that the minimum effective analgesic concentration of the opioid is more quickly achieved. These sustained release opioid formulations include an effective amount of at least one retardant material to cause said opioid analgesic to be released at a such a rate as to provide an analgesic effect after oral administration to a human patient for at least about 24 hours, and are characterized by providing an absorption half-life from 1 to about 8 hours. A method of titrating a human patient utilizing these sustained release opioid formulations is also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • PURDUE PHARMA L.P.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Goldenheim, Paul Wilton, CT 30 2992
Kaiko, Robert F Weston, CT 47 4159
Sackler, Richard S Greenwich, CT 43 1462

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation